Table 2 |
|||||
|
Adjusted predicted probabilities and risk ratios for relationship between RA and diabetes testing (N = 256,331)* |
|||||
|
Unadjusted testing (%) |
Adjusted predicted probability (%) |
95% CI |
Odds ratio |
95% CI |
|
|
|
|||||
|
Receipt of ≥2 A1c test |
|||||
|
DM no RA |
56.9 |
57.1 |
56.9 to 57.3 |
Referent |
|
|
DM + RA |
51.8 |
53.2 |
51.8 to 54.5 |
0.84 |
0.80 to 0.89 |
|
Receipt of ≥1 LDL test |
|||||
|
DM no RA |
76.7 |
76.7 |
76.5 to 76.8 |
Referent |
|
|
DM + RA |
75.5 |
77.8 |
76.8 to 78.8 |
1.08 |
1.01 to 1.16 |
|
|
|||||
|
*Models also adjusted for age, gender, race/ethnicity, Medicaid buy-in, RUCA code, HCC quartile, hospitalization in a three-year period, specific co-morbidities including diabetes complications, hyperlipidemia, chronic kidney disease, CVD, orthopedic surgeries, gait device, PCP visits and total providers. |
|||||
|
Bartels et al. Arthritis Research & Therapy 2012 14:R166 doi:10.1186/ar3915 |
|||||